Myriad Genetics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MYGN and other ETFs, options, and stocks.

About MYGN

Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic tests. The company was founded by Walter A. 

CEO
Samraat S Raha
CEOSamraat S Raha
Employees
2,700
Employees2,700
Headquarters
Salt Lake City, Utah
HeadquartersSalt Lake City, Utah
Founded
1991
Founded1991
Employees
2,700
Employees2,700

MYGN Key Statistics

Market cap
485.31M
Market cap485.31M
Price-Earnings ratio
-1.34
Price-Earnings ratio-1.34
Dividend yield
Dividend yield
Average volume
2.14M
Average volume2.14M
High today
$5.33
High today$5.33
Low today
$4.98
Low today$4.98
Open price
$5.11
Open price$5.11
Volume
676.77K
Volume676.77K
52 Week high
$11.44
52 Week high$11.44
52 Week low
$3.76
52 Week low$3.76

Stock Snapshot

Myriad Genetics(MYGN) stock is priced at $5.19, giving the company a market capitalization of 485.31M. It carries a P/E multiple of -1.34.

As of 2026-03-05, Myriad Genetics(MYGN) stock has fluctuated between $4.98 and $5.33. The current price stands at $5.19, placing the stock +4.2% above today's low and -2.6% off the high.

Myriad Genetics(MYGN) shares are trading with a volume of 676.77K, against a daily average of 2.14M.

In the last year, Myriad Genetics(MYGN) shares hit a 52-week high of $11.44 and a 52-week low of $3.76.

In the last year, Myriad Genetics(MYGN) shares hit a 52-week high of $11.44 and a 52-week low of $3.76.

MYGN News

TipRanks 3d
Myriad Genetics Earnings Call Highlights Growth Amid Headwinds

Myriad Genetics ((MYGN)) has held its Q4 earnings call. Read on for the main highlights of the call. Claim 50% Off TipRanks Premium Unlock hedge fund-level data...

TipRanks 6d
Insider Move at Myriad Genetics Sparks Fresh Investor Buzz

New insider activity at Myriad Genetics ( (MYGN) ) has taken place on February 27, 2026. Director Louise Phanstiel has significantly increased her stake in Myr...

Analyst ratings

54%

of 13 ratings
Buy
23.1%
Hold
53.8%
Sell
23.1%

People also own

Based on the portfolios of people who own MYGN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.